ERIS LIFESCIENCES
Back to Balance Sheet
|
ERIS LIFESCIENCES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹229 Cr | ₹227 Cr | ₹-16 Cr | ₹-197 Cr | ₹-151 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ERIS LIFESCIENCES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹229 Cr |
| Mar2024 | ₹227 Cr |
| Mar2023 | ₹-16 Cr |
| Mar2022 | ₹-197 Cr |
| Mar2021 | ₹-151 Cr |
How is Deferred Tax Assets / Liabilities of ERIS LIFESCIENCES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹229 Cr | 0.87 | |
| Mar2024 | ₹227 Cr | Positive | |
| Mar2023 | ₹-16 Cr | Negative | |
| Mar2022 | ₹-197 Cr | Negative | |
| Mar2021 | ₹-151 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹18,603.3 Cr | -2.7% | -13% | 9.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹393,323.0 Cr | 1.7% | -5.7% | -7.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,825.0 Cr | 0.8% | -6.7% | 3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,349.0 Cr | 0.6% | 4.3% | 24.4% | Stock Analytics | |
| CIPLA | ₹106,048.0 Cr | -4.7% | -12.3% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,494.0 Cr | 6.3% | -2.1% | -4.1% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | -2.7% |
-13% |
9.7% |
| SENSEX | -1.7% |
-4.3% |
6.2% |
You may also like the below Video Courses